Synergy Innovation Co., Ltd.
Financials
Valuation Metrics
Synergy Innovation Co., Ltd.'s Market Cap is ₩1322B. At end of 2025 it was ₩2066B. Ranked #1096 of 2,421 in KR market (top 45%), #569 of 1,640 on KOSDAQ (top 35%), #38 of 96 in Health Care Equipment & Services (top 40%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 132.16B KRW | KR#1,096/2,421 Sec#38/96 |
| Revenue | 116.56B KRW | KR#1,330/2,421 Sec#27/96 |
| Net Income | 18.54B KRW | KR#729/2,421 Sec#18/96 |
| Total Assets | 345.29B KRW | KR#957/2,421 Sec#18/96 |
| Net Assets | 282.74B KRW | KR#742/2,421 Sec#14/96 |
| Employees | 69 | KR#1,887/2,421 Sec#76/96 |
| Value | ||
| P/E | 7.13x | KR#571/2,421 Sec#12/96 |
| P/B | 0.47x | KR#724/2,421 Sec#9/96 |
| PEG | 0.03x | KR#248/2,421 Sec#12/96 |
| P/S | 1.13x | KR#1,461/2,421 Sec#34/96 |
| EV/EBITDA | 5.79x | KR#292/2,421 Sec#10/96 |
| FCF Yield | 7.12% | KR#720/2,421 Sec#19/96 |
| Profitability | ||
| ROE | 6.56% | KR#929/2,421 Sec#37/96 |
| ROA | 5.37% | KR#694/2,421 Sec#31/96 |
| Op. Margin | 16.20% | KR#260/2,421 Sec#21/96 |
| Revenue Growth | 16.45% | KR#642/2,421 Sec#36/96 |
| Earnings Growth | 228.03% | KR#221/2,421 Sec#11/96 |
| Financial Health | ||
| Debt Ratio | 22.12% | KR#420/2,421 Sec#23/96 |
| Total Debt | 22.37B KRW | KR#1,338/2,421 Sec#38/96 |
| FCF | 9.41B KRW | KR#724/2,421 Sec#17/96 |
| Cash | 45.14B KRW | KR#786/2,421 Sec#17/96 |
| Current Ratio | 4.19x | KR#360/2,421 Sec#25/96 |
| Net Debt/EBITDA | -1.21x | KR#336/2,421 Sec#12/96 |
| Dividend | ||
| Div. Yield | 3.74% | KR#469/2,421 Sec#5/96 |
| Div. Growth | 25.73% | KR#387/2,421 Sec#15/96 |
| Performance | ||
| 1Y Return | -46.33% | KR#1,976/2,421 Sec#65/96 |
| 1M Return | -5.96% | KR#1,865/2,421 Sec#61/96 |
| From 52W High | -49.32% | KR#1,366/2,421 Sec#43/96 |
| 1Y MDD | -49.30% | KR#955/2,421 Sec#35/96 |
| Trading | ||
| Volume | 173,068 shares | KR#535/2,421 Sec#19/96 |
| Trading Value | 257.7M KRW | KR#1,175/2,421 Sec#44/96 |
| Foreign Own. | 14.23% | KR#337/2,421 Sec#9/96 |
| Per Share | ||
| EPS | 210 KRW | KR#1,268/2,421 Sec#38/96 |
| BPS | 3,209 KRW | KR#1,812/2,421 Sec#54/96 |
Company Info
Synergy Innovation, established in 1998 and listed on KOSDAQ in 2004, is a specialized microorganism culture media manufacturing company with five subsidiaries. It operates biotechnology, medical, and health functional food businesses, including investing in new drug development for brain and central nervous system diseases through Neurobiogen. The company produces in-vitro diagnostic and environmental monitoring products in ISO13485 and KGMP-certified environments, focusing on manufacturing facility expansion and production automation from 2024, from its headquarters in Seongnam-si, Gyeonggi-do.